Skip to main content
Equibles
MMSI logo

MMSI · Merit Medical Systems Inc

Track MMSI — free

Use MMSI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$89.60 +1.03 (+1.16%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.35B
Shares
59.71M

MMSI metrics

84 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$89.60
Market cap
$5.35B

Price action

19 metrics
Price change (1W)
-1.0%
Price change (30D)
-0.2%
Price change (3M)
+39.0%
Price change (6M)
+23.3%
Price change (YTD)
+1.7%
Price change (1Y)
-2.8%
Trailing year
Price change (5Y)
+22.8%
52-week high
$93.18
52-week low
$60.31
Change from 52-week high
-3.8%
Change from 52-week low
+48.6%
Annualized volatility
30.3%
Beta
0.5
RSI (14D)
58.6
Price vs SMA 50
+9.5%
Price vs SMA 200
+16.9%
Avg volume (3M)
885,210
Relative volume
0.7
Average dollar volume
$70.09M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
59.71M

Valuation

12 metrics
P / E (TTM)
36.9
Trailing earnings · reciprocal yield 2.7%
PEG ratio
1.8
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.4×
reciprocal yield 29.5%
P / book
3.2
reciprocal yield 31.4%
FCF yield
3.8%
TTM · current market cap
Buyback yield
—
P / FCF
26.3
reciprocal yield 3.8%
P / operating cash flow
18.9
reciprocal yield 5.3%
Earnings yield
2.7%

Historical valuation

8 metrics
P / E historical average (3Y)
41.8×
reciprocal yield 2.4%
P / E historical average (5Y)
55.3×
reciprocal yield 1.8%
EV / revenue historical average (3Y)
3.7×
reciprocal yield 26.9%
EV / revenue historical average (5Y)
3.7×
reciprocal yield 27.1%
EV / EBIT historical average (3Y)
33.0×
reciprocal yield 3.0%
EV / EBIT historical average (5Y)
44.5×
reciprocal yield 2.2%
EV / EBITDA historical average (3Y)
18.9×
reciprocal yield 5.3%
EV / EBITDA historical average (5Y)
21.9×
reciprocal yield 4.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
49.5%
Operating margin
12.8%
Trailing 12 months
Net margin
9.2%
Gross profit (TTM)
$781.73M
Operating profit (TTM)
$201.37M
Net income (TTM)
$145.56M
Trailing 12 months
Diluted EPS (TTM)
$2.43
FCF margin
12.9%
Effective tax rate
25.1%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+9.5%
Year over year
Net income growth YoY
+19.1%
Revenue (TTM)
$1.58B
Trailing 12 months
EPS growth YoY
+20.4%
Shares change YoY
-1.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+9.6%
Revenue CAGR (5Y)
+9.5%
EPS CAGR (3Y)
+18.2%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+46.0%
FCF CAGR (5Y)
+12.6%

Quality

14 metrics
Return on equity
8.7%
Return on assets
5.1%
Debt / equity
—
Current ratio
4.2
EBITDA (TTM)
$325.74M
Free cash flow (TTM)
$203.21M
Quick ratio
2.8
Interest coverage
6.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$448.70M
Total assets
$2.86B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$283.45M
Capital expenditures (TTM)
$80.24M
R&D (TTM)
$98.50M
SG&A (TTM)
$482.07M
Stock compensation (TTM)
$45.38M
R&D / revenue
6.2%
Stock compensation / revenue
2.9%

Ownership (13F)

3 metrics
13F filers
405
13F filer change QoQ
+3
Institutional ownership
106.3%

Short interest

3 metrics
Short interest
5.8%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
54 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$2.50M
Insider-sentiment score
33 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 856982 CUSIP 589889104 13F (30d) 226 filings 225 filers Visit website